CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lincoln Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lincoln Pharmaceuticals Ltd
LINCOLN HOUSE, B/h. Satyam Complex
Science City Road, Sola
Phone: +91 7967778000p:+91 7967778000 AHMEDABAD, 380060  India Ticker: LINCOLNLINCOLN
Business Summary
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceutical products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, anti-diabetic, and anti-malaria. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms), and Tinnex Capsule used to treat tinnitus.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Non-Independent Chairman of the Board Kishor M.Shah 78 8/16/1995 8/16/1995
Chief Financial Officer Darshit A.Shah
Compliance Officer, Company Secretary TrushaShah 28 11/10/2022 11/10/2022
8 additional Officers and Directors records available in full report.

Business Names
Business Name
531633
LINCOLN
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd(NDA)

General Information
Number of Employees: 1,700 (As of 3/31/2024)
Outstanding Shares: 20,029,728 (As of 9/30/2024)
Shareholders: 31,973
Stock Exchange: NSE
Fax Number: +91 7930018062


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024